These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8658689

  • 1. Long-term results of OKT3-treated renal transplant recipients.
    Tanabe K, Takahashi K, Sonda K, Tokumoto T, Koga S, Nakazawa H, Goya N, Yagisawa T, Fuchinoue S, Kawai T, Toma H, Ota K.
    Transplant Proc; 1996 Jun; 28(3):1350-1. PubMed ID: 8658689
    [No Abstract] [Full Text] [Related]

  • 2. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
    Kumano K, Irie A, Mashimo S, Endo T, Koshiba K.
    Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
    Stratta RJ, Taylor RJ, Weide LG, Sindhi R, Sudan D, Castaldo P, Cushing KA, Frisbie K, Radio SJ.
    Transplant Proc; 1996 Apr; 28(2):917-8. PubMed ID: 8623461
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective trial of OKT3 for early prophylaxis of rejection in immunologic "high risk" renal transplant recipients: long-term results.
    Pomer S, Waldherr R, Möhring K, Kempter F, Wiesel M, Weimer R.
    Transplant Proc; 1992 Oct; 24(5):1732-3. PubMed ID: 1412815
    [No Abstract] [Full Text] [Related]

  • 12. Kidney transplantation in children.
    Cuhadaroğlu S, Velidedeoğlu E, Haberal M.
    Transplant Proc; 1993 Jun; 25(3):2174-5. PubMed ID: 8516858
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group.
    Transplant Proc; 1994 Oct; 26(5):2522-4. PubMed ID: 7940775
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H, Sakamoto K, Kashiwabara H, Hachisu T, Yamada H, Matsushita K, Yamada K, Yokoyama T.
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract] [Full Text] [Related]

  • 19. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S, Alexander JW, Schroeder TJ, First MR.
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [Abstract] [Full Text] [Related]

  • 20. Consequences of anti-OKT3 antibody development: OKT3 reuse and long-term graft survival.
    Shield CF.
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):81-2. PubMed ID: 8465434
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.